Skip to main navigation
Skip to search
Skip to main content
Tel Aviv University Home
Update Request & User Guide (TAU staff only)
Home
Experts
Research units
Research output
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
Augmentation with typical antipsychotics for patients who partially respond to antipsychotics
D. Mazeh
,
Y. Melamed
Clinical Departments
Psychiatry
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Augmentation with typical antipsychotics for patients who partially respond to antipsychotics'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
5-HT2
25%
Antipsychotic Activity
25%
Antipsychotics
100%
Clinical Significance
25%
Clozapine
100%
Combination Regimen
25%
D2 Antagonist
25%
D2 Receptor
25%
Dopamine Antagonist
50%
Haloperidol
75%
Israel
25%
Low Affinity
25%
New Drugs
25%
Number of Patients
25%
Olanzapine
100%
Patient Benefit
25%
Psychotic Patients
25%
Schizophrenia
25%
Serotonin
50%
Sulpiride
75%
Typical Antipsychotics
100%
Zuclopenthixol
50%
Neuroscience
Antipsychotic
20%
Clozapine
80%
D2 Antagonists
20%
Dementia Praecox
20%
Dopamine Antagonist
40%
Haloperidol
60%
Levosulpiride
60%
Olanzapine
80%
Psychosis
20%
Serotonin
40%
Sulpiride
60%
Typical Antipsychotic
100%
Zuclopenthixol
40%
Pharmacology, Toxicology and Pharmaceutical Science
4 (para chlorophenyl) 1 [3 (para fluorobenzoyl)propyl] 4 piperidinol
60%
Antipsychotic
60%
Clozapine
80%
Dopamine Receptor Blocking Agent
40%
Olanzapine
80%
Psychosis
20%
Serotonin
40%
Sulpiride
60%
Typical Antipsychotic
100%
Zuclopenthixol
40%